Standard BioTools Inc (NAS:LAB)
$ 1.82 -0.08 (-4.21%) Market Cap: 707.29 Mil Enterprise Value: 404.38 Mil PE Ratio: 0 PB Ratio: 1.45 GF Score: 51/100

Q1 2021 Fluidigm Corp Earnings Call Transcript

May 06, 2021 / 09:00PM GMT
Release Date Price: $4.59 (-5.94%)
Operator

Good day, and thank you for standing by. Welcome to the Fluidigm First Quarter 2021 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today. Peter DeNardo with Investor Relations. Thank you. Please go ahead.

Peter Denardo

Thank you, Mike. Good afternoon, everyone. Welcome to Fluidigm's First Quarter 2021 Earnings Conference Call. At the close of market today, Fluidigm released its financial results for the first quarter ended March 31, 2021. During this call, we will review our results and provide commentary on our financial and operational performance, market trends, strategic initiatives and our response to the COVID-19 pandemic.

Presenting for Fluidigm today will be Chris Linthwaite, our President and CEO; and Vikram Jog, our CFO.

During the call and subsequent Q&A session, we will make forward-looking statements about events and circumstances that have not yet occurred, including

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot